Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Viatris (VTRS) Q1 Earnings and Revenues Surpass Estimates
Viatris (VTRS) Q1 Earnings and Revenues Surpass Estimates

Viatris (VTRS) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.52 per share. This compares to earnings of $0.5 per share a year ago. These figures are

N-able (NABL) Matches Q1 Earnings Estimates
N-able (NABL) Matches Q1 Earnings Estimates

N-able (NABL) came out with quarterly earnings of $0.09 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.08 per share a year ago. These figures are adjusted for

Nomad Foods (NOMD) Surpasses Q1 Earnings and Revenue Estimates
Nomad Foods (NOMD) Surpasses Q1 Earnings and Revenue Estimates

Nomad Foods (NOMD) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.37 per share a year ago. These

Middleby (MIDD) Surpasses Q1 Earnings and Revenue Estimates
Middleby (MIDD) Surpasses Q1 Earnings and Revenue Estimates

Middleby (MIDD) came out with quarterly earnings of $2.16 per share, beating the Zacks Consensus Estimate of $1.94 per share. This compares to earnings of $2.08 per share a year ago. These figures

McDonald's (MCD) Q1 Earnings and Revenues Top Estimates
McDonald's (MCD) Q1 Earnings and Revenues Top Estimates

McDonald's (MCD) came out with quarterly earnings of $2.83 per share, beating the Zacks Consensus Estimate of $2.74 per share. This compares to earnings of $2.67 per share a year ago. These figures

Maximus (MMS) Q2 Earnings Beat Estimates
Maximus (MMS) Q2 Earnings Beat Estimates

Maximus (MMS) came out with quarterly earnings of $2.07 per share, beating the Zacks Consensus Estimate of $1.98 per share. This compares to earnings of $2.01 per share a year ago. These figures are

MasterCraft Boat Holdings, Inc. (MCFT) Q3 Earnings and Revenues Surpass Estimates
MasterCraft Boat Holdings, Inc. (MCFT) Q3 Earnings and Revenues Surpass Estimates

MasterCraft Boat Holdings, Inc. (MCFT) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.3 per share a

Kontoor Brands (KTB) Q1 Earnings and Revenues Miss Estimates
Kontoor Brands (KTB) Q1 Earnings and Revenues Miss Estimates

Kontoor Brands (KTB) came out with quarterly earnings of $1.06 per share, missing the Zacks Consensus Estimate of $1.17 per share. This compares to earnings of $1.2 per share a year ago. These

Kimbell Royalty (KRP) Q1 Earnings and Revenues Miss Estimates
Kimbell Royalty (KRP) Q1 Earnings and Revenues Miss Estimates

Kimbell Royalty (KRP) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.2 per share a year ago. These

Kenvue (KVUE) Q1 Earnings and Revenues Beat Estimates
Kenvue (KVUE) Q1 Earnings and Revenues Beat Estimates

Kenvue (KVUE) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.24 per share a year ago. These figures are

Lexicon Pharmaceuticals (LXRX) Reports Break-Even Earnings for Q1Photo, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Lexicon Pharmaceuticals (LXRX) Reports Break-Even Earnings for Q1

Lexicon Pharmaceuticals (LXRX) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.07 per share a year ago. These

Lifetime Brands (LCUT) Q1 Earnings and Revenues Surpass Estimates
Lifetime Brands (LCUT) Q1 Earnings and Revenues Surpass Estimates

Lifetime Brands (LCUT) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.18 per share. This compares to a loss of $0.25 per share a year ago

Evergy Inc (EVRG) Surpasses Q1 Earnings and Revenue Estimates
Evergy Inc (EVRG) Surpasses Q1 Earnings and Revenue Estimates

Evergy Inc (EVRG) came out with quarterly earnings of $0.69 per share, beating the Zacks Consensus Estimate of $0.63 per share. This compares to earnings of $0.54 per share a year ago. These figures

Kelly Services (KELYA) Q1 Earnings Lag Estimates
Kelly Services (KELYA) Q1 Earnings Lag Estimates

Kelly Services (KELYA) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.39 per share a year ago. These

Griffon (GFF) Q2 Earnings and Revenues Surpass Estimates
Griffon (GFF) Q2 Earnings and Revenues Surpass Estimates

Griffon (GFF) came out with quarterly earnings of $1.05 per share, beating the Zacks Consensus Estimate of $0.99 per share. This compares to earnings of $1.23 per share a year ago. These figures are

Ispire Technology Inc. (ISPR) Reports Q3 Loss, Lags Revenue Estimates
Ispire Technology Inc. (ISPR) Reports Q3 Loss, Lags Revenue Estimates

Ispire Technology Inc. (ISPR) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.19 per share a year ago. These

Foghorn Therapeutics Inc. (FHTX) Reports Q1 Loss, Lags Revenue Estimates
Foghorn Therapeutics Inc. (FHTX) Reports Q1 Loss, Lags Revenue Estimates

Foghorn Therapeutics Inc. (FHTX) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to a loss of $0.3 per share a year ago. These

Ironwood Pharmaceuticals (IRWD) Tops Q1 Earnings and Revenue EstimatesPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
Ironwood Pharmaceuticals (IRWD) Tops Q1 Earnings and Revenue Estimates

Ironwood Pharmaceuticals (IRWD) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to a loss of $0.14 per share a year ago

International Seaways (INSW) Surpasses Q1 Earnings and Revenue Estimates
International Seaways (INSW) Surpasses Q1 Earnings and Revenue Estimates

International Seaways (INSW) came out with quarterly earnings of $3.9 per share, beating the Zacks Consensus Estimate of $2.48 per share. This compares to earnings of $0.8 per share a year ago

Insmed (INSM) Reports Q1 Loss, Misses Revenue Estimates
Insmed (INSM) Reports Q1 Loss, Misses Revenue Estimates

Insmed (INSM) came out with a quarterly loss of $0.76 per share versus the Zacks Consensus Estimate of a loss of $0.9. This compares to a loss of $1.42 per share a year ago. These figures are

Harmony Biosciences Holdings, Inc. (HRMY) Q1 Earnings and Revenues Miss Estimates
Harmony Biosciences Holdings, Inc. (HRMY) Q1 Earnings and Revenues Miss Estimates

Harmony Biosciences Holdings, Inc. (HRMY) came out with quarterly earnings of $0.55 per share, missing the Zacks Consensus Estimate of $0.76 per share. This compares to earnings of $0.78 per share a

Installed Building Products (IBP) Lags Q1 Earnings and Revenue Estimates
Installed Building Products (IBP) Lags Q1 Earnings and Revenue Estimates

Installed Building Products (IBP) came out with quarterly earnings of $1.79 per share, missing the Zacks Consensus Estimate of $2.09 per share. This compares to earnings of $2.08 per share a year

ARKO Corp. (ARKO) Reports Q1 Loss, Beats Revenue Estimates
ARKO Corp. (ARKO) Reports Q1 Loss, Beats Revenue Estimates

ARKO Corp. (ARKO) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to a loss of $0.12 per share a year ago. These figures are

Iovance Biotherapeutics (IOVA) Reports Q1 Loss, Lags Revenue Estimates
Iovance Biotherapeutics (IOVA) Reports Q1 Loss, Lags Revenue Estimates

Iovance Biotherapeutics (IOVA) came out with a quarterly loss of $0.19 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.36 per share a year ago. These figures are

OppFi Inc. (OPFI) Q1 Earnings and Revenues Top Estimates
OppFi Inc. (OPFI) Q1 Earnings and Revenues Top Estimates

OppFi Inc. (OPFI) came out with quarterly earnings of $0.35 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.38 per share a year ago. These figures